Cataract
Cataract | |
---|---|
Classification and external resources | |
File:Cataract in human eye.png Magnified view of cataract in human eye, seen on examination with a slit lamp using diffuse illumination | |
ICD-10 | H25.-H26., H28., Q12.0 |
ICD-9 | 366 |
DiseasesDB | 2179 |
MedlinePlus | 001001 |
A cataract is a clouding that develops in the crystalline lens of the eye or in its envelope, varying in degree from slight to complete opacity and obstructing the passage of light. Early in the development of age-related cataract the power of the lens may be increased, causing near-sightedness (myopia), and the gradual yellowing and opacification of the lens may reduce the perception of blue colours. Cataracts typically progress slowly to cause vision loss and are potentially blinding if untreated. The condition usually affects both the eyes, but almost always one eye is affected earlier than the other.[1]
A senile cataract, occurring in the elderly, is characterized by an initial opacity in the lens, subsequent swelling of the lens and final shrinkage with complete loss of transparency.[2] Moreover, with time the cataract cortex liquefies to form a milky white fluid in a Morgagnian cataract, which can cause severe inflammation if the lens capsule ruptures and leaks. Untreated, the cataract can cause phacomorphic glaucoma. Very advanced cataracts with weak zonules are liable to dislocation anteriorly or posteriorly. Such spontaneous posterior dislocations (akin to the historical surgical procedure of couching) in ancient times were regarded as a blessing from the heavens, because some perception of light was restored in the cataractous patients.
Cataract derives from the Latin cataracta meaning "waterfall" and the Greek kataraktes and katarrhaktes, from katarassein meaning "to dash down" (kata-, "down"; arassein, "to strike, dash").[3] As rapidly running water turns white, the term may later have been used metaphorically to describe the similar appearance of mature ocular opacities. In Latin, cataracta had the alternate meaning "portcullis",[4] so it is also possible that the name came about through the sense of "obstruction". Early Persian physicians called the term nazul-i-ah, or "descent of the water"—vulgarised into waterfall disease or cataract—believing such blindness to be caused by an outpouring of corrupt humour into the eye.[5] In dialect English a cataract is called a pearl, as in "pearl eye" and "pearl-eyed".[6]
Contents
Epidemiology
Age-related cataract is responsible for 48% of world blindness, which represents about 18 million people, according to the World Health Organization (WHO).[8] In many countries surgical services are inadequate, and cataracts remain the leading cause of blindness. As populations age, the number of people with cataracts is growing. Cataracts are also an important cause of low vision in both developed and developing countries. Even where surgical services are available, low vision associated with cataracts may still be prevalent, as a result of long waits for operations and barriers to surgical uptake, such as cost, lack of information and transportation problems.
In the United States, age-related lenticular changes have been reported in 42% of those between the ages of 52 to 64,[9] 60% of those between the ages 65 and 74,[10] and 91% of those between the ages of 75 and 85.[9]
The increase in ultraviolet radiation resulting from depletion of the ozone layer is expected to increase the incidence of cataracts.[11]
History
The earliest records are from the Bible as well as early Hindu records.[12] Early cataract surgery was developed by the Indian surgeon, Sushruta (6th century BCE).[13] The Indian tradition of cataract surgery was performed with a special tool called the Jabamukhi Salaka, a curved needle used to loosen the lens and push the cataract out of the field of vision.[13] The eye would later be soaked with warm butter and then bandaged.[13] Though this method was successful, Sushruta cautioned that it should only be used when necessary.[13] Greek physicians and philosophers traveled to India where these surgeries were performed by physicians.[13] The removal of cataract by surgery was also introduced into China from India.[14]
The first references to cataract and its treatment in Ancient Rome are found in 29 CE in De Medicinae, the work of the Latin encyclopedist Aulus Cornelius Celsus.[15] The Romans were pioneers in the health arena—particularly in the area of eye care.[16]
The Muslim ophthalmologist Ammar ibn Ali of Mosul performed the first extraction of cataracts through suction. He invented a hollow metallic syringe hypodermic needle, which he applied through the sclerotic and extracted the cataracts using suction.[17] In his Choice of Eye Diseases, written circa 1000 CE, he wrote of his invention of the hypodermic needle and how he discovered the technique of cataract extraction while experimenting with it on a patient.[18]
Classification
The following is a classification of the various types of cataracts. This is not comprehensive and other unusual types may be noted.
- Classified by etiology
- Age-related cataract
- Cortical Senile Cataract
- Immature senile cataract (IMSC): partially opaque lens, disc view hazy
- Mature senile cataract (MSC): Completely opaque lens, no disc view
- Hypermature senile cataract (HMSC): Liquefied cortical matter: Morgagnian cataract
- Senile Nuclear Cataract
- Cataracta brunescens
- cataracta nigra
- cataracta rubra
- Congenital cataract
- Sutural cataract
- Lamellar cataract
- Zonular cataract
- Total cataract
- Drug-induced cataract (e.g. corticosteroids)
- Traumatic cataract
- Blunt trauma (capsule usually intact)
- Penetrating trauma (capsular rupture & leakage of lens material—calls for an emergency surgery for extraction of lens and leaked material to minimize further damage)
- Classified by opacities, cataract can be classified by using Lens Opacities Classification System III (LOCS III: Nuclear NC1-5, Cortical C1-5 and Posterior P1-5. By application planning in procedures of phacoemulsification, LCOS III can be converted in newer cataract grading system. Gede Pardianto (2009) introduced Optical Biometry Based Cataract Grading System (OBBCGS) that so helpful in cataract grading due to phacoemulsification planning. LOCS III's NC0, C0 and P0 acan be converted as OBBCGS' No cataract (NC), LOCS III's NC1-3, C1-3, P1-4 can be converted to OBBCGS' Optical Biometry Examined Cataract (OBEC) and LOCS III's NC4-5, C4-5, P4-5 can be converted to OBBCGS's Optical Biometry Un-examined Cataract (OBUC); that need examination by Applanation Ultrasound Biometry.[19]
- Classified by location of opacity within lens structure (However, mixed morphology is quite commonly seen, e.g. PSC with nuclear changes & cortical spokes of cataract)
- Anterior cortical cataract
- Anterior polar cataract
- Anterior subcapsular cataract
- Nuclear cataract—Grading correlates with hardness & difficulty of surgical removal
- Posterior cortical cataract
- Posterior polar cataract (importance lies in higher risk of complication—posterior capsular tears during surgery)
- Posterior subcapsular cataract (PSC) (clinically common)
- After-cataract: posterior capsular opacification (PCO) subsequent to a successful extracapsular cataract surgery (usually within three months to two years) with or without IOL implantation. Requires a quick & painless office procedure with Nd:YAG laser capsulotomy to restore optical clarity.
Signs and symptoms
As a cataract becomes more opaque, clear vision is compromised. A loss of visual acuity is noted. Contrast sensitivity is also lost, so that contours, shadows and color vision are less vivid. Veiling glare can be a problem as light is scattered by the cataract into the eye. The affected eye will have an absent red reflex. A contrast sensitivity test should be performed and if a loss in contrast sensitivity is demonstrated an eye specialist consultation is recommended.
In the developed world, particularly in high-risk groups such as diabetics, it may be advisable to seek medical opinion if a 'halo' is observed around street lights at night, especially if this phenomenon appears to be confined to one eye only.
The symptoms of cataracts are very similar to the symptoms of ocular citrosis.
Causes
Cataracts develop for a variety of reasons, including long-term exposure to ultraviolet light, exposure to radiation, secondary effects of diseases such as diabetes, hypertension and advanced age, or trauma (possibly much earlier); they are usually a result of denaturation of lens protein. Genetic factors are often a cause of congenital cataracts and positive family history may also play a role in predisposing someone to cataracts at an earlier age, a phenomenon of "anticipation" in pre-senile cataracts. Cataracts may also be produced by eye injury or physical trauma. A study among Icelandair pilots showed commercial airline pilots are three times more likely to develop cataracts than people with non-flying jobs. This is thought to be caused by excessive exposure to radiation coming from outer space.[20] Cataracts are also unusually common in persons exposed to infrared radiation, such as glassblowers who suffer from "exfoliation syndrome". Exposure to microwave radiation can cause cataracts. Atopic or allergic conditions are also known to quicken the progression of cataracts, especially in children.[21] Cataracts can also be caused by iodine deficiency[22]
Cataracts may be partial or complete, stationary or progressive, hard or soft.
Some drugs can induce cataract development, such as corticosteroids[23] and Seroquel.
There are various types of cataracts, e.g. nuclear, cortical, mature, and hypermature. Cataracts are also classified by their location, e.g. posterior (classically due to steroid use[23][24]) and anterior (common (senile) cataract related to ageing).
Associations with systemic conditions
- Disease of the skin and mucous membranes
- Congenital
- Others
- Toxic substances introduced systemically
Prevention
Although cataracts have no scientifically proven prevention, it is sometimes said that wearing ultraviolet-protecting sunglasses may slow the development of cataracts.[25][26] Regular intake of antioxidants (such as vitamin A, C and E) is theoretically helpful, but taking them as a supplement has been shown to have no benefit.[27] The less well known antioxidant N-acetylcarnosine has been shown in randomized controlled clinical trials to treat cataracts, and can be expected to prevent their formation by similar mechanisms.[28] N-acetylcarnosine is a proposed treatment for other ocular disorders that are instigated, or exacerbated by oxidative stress including glaucoma, retinal degeneration, corneal disordes, and ocular inflammation.[29]
Treatment
When a cataract is sufficiently developed to be removed by surgery, the most effective and common treatment is to make an incision (capsulotomy) into the capsule of the cloudy lens in order to surgically remove the lens. There are two types of eye surgery that can be used to remove cataracts: extra-capsular (extracapsular cataract extraction, or ECCE) and intra-capsular (intracapsular cataract extraction, or ICCE).
Extra-capsular (ECCE) surgery consists of removing the lens but leaving the majority of the lens capsule intact. High frequency sound waves (phacoemulsification) are sometimes used to break up the lens before extraction.
Intra-capsular (ICCE) surgery involves removing the entire lens of the eye, including the lens capsule, but it is rarely performed in modern practice.
In either extra-capsular surgery or intra-capsular surgery, the cataractous lens is removed and replaced with a plastic lens (an intraocular lens implant) which stays in the eye permanently.
Cataract operations are usually performed using a local anaesthetic and the patient is allowed to go home the same day. Recent improvements in intraocular technology now allow cataract patients to choose a multifocal lens to create a visual environment in which they are less dependent on glasses. Under some medical systems multifocal lenses cost extra. Traditional intraocular lenses are monofocal.
Complications are possible after cataract surgery, including endophthalmitis, posterior capsular opacification and retinal detachment.
Research
Research is scant and mixed but weakly positive for the nutrients lutein and zeaxanthin.[30][31][32][33] Bilberry extract shows promise in rat models [34][35] and in clinical studies.[36]
Investigational Treatments
In the past few years, eye drops containing acetyl-carnosine have been used by several thousands cataract patients across the world. The drops are believed to work by reducing oxidation and glycation damage in the lens, particularly reducing crystallin cross-linking.[37][38] Randomized controlled trials indicate the drops may be especially appropriate for seniors, or others where surgery is not advised.[39]
Investigational preventives
Although statins are known for their ability to lower lipids, they are also believed to have antioxidant qualities. It is believed that oxidative stress plays a role in the development of nuclear cataracts, which are the most common type of age-related cataract. To explore the relationship between nuclear cataracts and statin use, a group of researchers took a group of 1299 patients who were at risk of developing nuclear cataracts and gave some of them statins. Their results suggest that statin use in an at-risk population may be associated with a lower risk of developing nuclear cataract disease.[40]
Long term (avg 5 year) observation showed that systematic application of azapentacene sodium polysulfonate (Quinax) slows down the progress of the disease.[41]
See also
- List of eye diseases
- List of eye diseases and disorders
- List of systemic diseases with ocular manifestations
References and notes
- Pavan-Langston, Deborah (1990). Manual of Ocular Diagnosis and Therapy. Little, Brown and Company.
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
External links
- Cataract Resource Guide from the National Eye Institute (NEI), nei.nih.gov
- eMedicine Health, emedicinehealth.com
- The Childhood Cataract Network, childhoodcataracts.org.uk
- Pediatric Glaucoma and Cataract Family Association, pgcfa.org
- Online Eye Info
ar:الساد bg:Катаракта ca:Cataracta cs:Šedý zákal de:Katarakt (Medizin) dv:ލޯފުސްވާ ބަލި et:Katarakt es:Catarata eo:Katarakto eu:Begi-lauso fa:آب مروارید fr:Cataracte (maladie) ko:백내장 hi:मोतियाबिंद hr:Siva mrena id:Katarak it:Cataratta he:קטרקט lt:Katarakta hu:Szürke hályog ml:തിമിരം ms:Katarak nl:Cataract (oogaandoening) ja:白内障 no:Grå stær nn:Katarakt pl:Zaćma pt:Catarata ro:Cataractă qu:Phuyu ñawi ru:Катаракта simple:Cataract sr:Катаракта sh:Katarakta fi:Harmaakaihi sv:Grå starr ta:கண்புரை tt:Катаракта te:శుక్లము tr:Katarakt uk:Катаракта ur:موتیا بند vi:Cườm thủy tinh thể mắt zh:白内障
arz:ميه بيضا- ↑ Common Causes of Vision Loss in Elderly Patients - July 1999 - American Academy of Family Physicians
- ↑ eMedicine - Cataract, Senile : Article by Vicente Victor D Ocampo. From eMedicine The Continually Updated Clinical Reference
- ↑ Dictionary.reference.com, Word of the Day Archive/cataract
- ↑ Online Etymology Dictionary, etymonline.com
- ↑ Mistaken Science - Topic Powered by eve community, Wordcraft Forums, wordcraft.infopop.cc
- ↑ Webster's Revised Unabridged Dictionary (1913 edition). Public Reference Tools - The ARTFL Project (American and French Research on the Treasury of the French Language), University of Chicago
- ↑ "Death and DALY estimates for 2004 by cause for WHO Member States" (xls). World Health Organization. who.int. 2004.
- ↑ WHO.int, | Priority eye diseases.
- ↑ 9.0 9.1 Sperduto RD, Seigel D. Sperduto RD, Seigel D. "Senile lens and senile macular changes in a population-based sample." Am J Ophthalmol. 1980 Jul;90(1):86-91. PMID 7395962.
- ↑ Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS, Dawber TR. "The Framingham Eye Study. I. Outline and major prevalence findings." Am J Epidemiol. 1977 Jul;106(1):17-32. PMID 879158.
- ↑ Dobson, R. (2005). "Ozone depletion will bring big rise in number of cataracts". BMJ. 331 (7528): 1292. doi:10.1136/bmj.331.7528.1292-d. PMC 1298892 Freely accessible. PMID 16322012.
- ↑ A short history of cataract surgery, rila.co.uk
- ↑ 13.0 13.1 13.2 13.3 13.4 Finger, page 66
- ↑ Lade & Svoboda, page 85
- ↑ Cataract history, mrcophth.com
- ↑ The Romans carried out cataract ops, NEWS.BBC.co.uk February 9, 2008, BBC News
- ↑ Ibrahim B. Syed PhD, "Islamic Medicine: 1000 years ahead of its times", Journal of the International Society for the History of Islamic Medicine 2 (2002): 2-9 [7].
- ↑ Finger, Stanley (1994). Origins of Neuroscience: A History of Explorations Into Brain Function. Oxford University Press. p. 70. ISBN 0195146948.
- ↑ Pardianto G, Mastering Phacoemulsification in Mimbar Ilmiah Oftalmologi Indonesia.2009;10: 24-5.
- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
- ↑ Buchberger W, Winkler R, Moser M, Rieger G "Influence of iodide on cataractogenesis in Emory mice", Ophthalmic Res 1991; 23, pages 303-8
- ↑ 23.0 23.1 Spencer R., Andelman S. (1965). "Steroid Cataracts. Posterior Subcapsular Cataract Formation In Rheumatoid Arthritis Patients On Long Term Steroid Therapy". Arch Ophthalmol. 74: 38–41. PMID 14303339.
- ↑ Greiner J, Chylack L (1979). "Posterior subcapsular cataracts: histopathologic study of steroid-associated cataracts". Arch Ophthalmol. 97 (1): 135–44. PMID 758890.
- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
- ↑ J.C. Javitt, F. Wang and S. K. West, “Blindness Due to Cataract: Epidemiology and Prevention.” Annual Review of Public Health 17 (1996): 159-77. Cited in Five-Year Agenda for the National Eye Health Education Program (NEHEP), p. B-2; National Eye Institute, U.S. National Institutes of Health
- ↑ A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001 Oct;119(10):1439-52
- ↑ N-Acetylcarnosine, a natural histidine-containing dipeptide, as a potent ophthalmic drug in treatment of human cataracts. Babizhayev MA, Deyev AI, Yermakova VN, Semiletov YA, Davydova NG, Kurysheva NI, Zhukotskii AV, Goldman IM. Peptides. 2001 Jun;22(6):979-94. PMID: 11390029
- ↑ The natural histidine-containing dipeptide Nalpha-acetylcarnosine as an antioxidant for ophthalmic use. Babizhayev MA, Yermakova VN, Semiletov YA, Deyev AI. Biochemistry (Mosc). 2000 May;65(5):588-98. PMID: 10851037
- ↑ Nutrition. 2003 Jan;19(1):21 Lutein, but not alpha-tocopherol, supplementation improves visual function] in patients with age-related cataracts: a 2-y double-blind, placebo-controlled pilot study
- ↑ Invest Ophthalmol Vis Sci. 2006 Septemner; 47(9):3783-6. Lutein and zeaxanthin and the risk of cataract: the Melbourne visual impairment project
- ↑ Invest Ophthalmol Vis Sci. 2006 June; 47(6):2329-35. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study
- ↑ J Am Coll Nutr. 2004 December; 23(6 Suppl):567S-587S Lutein and zeaxanthin and their potential roles in disease prevention
- ↑ Dietary supplementation with bilberry extract prevents macular degeneration and cataracts in senesce-accelerated OXYS rats Adv Gerontol. 2005;16:76-9
- ↑ Yamakoshi J, et al. J. Agric Food Chem. 2002 August 14;50(17):4983-8.
- ↑ Ann Ottalmol Clin Ocul, 1989
- ↑ Williams DL, Munday P. The effect of a topical antioxidant formulation including N-acetyl carnosine on canine cataract: a preliminary study. Vet Ophthalmol. 2006; 9(5):311-6
- ↑ Guo Y, Yan H. Preventive effect of carnosine on cataract development. Yan Ke Xue Bao. 2006; 22(2):85-8
- ↑ Efficacy of N-acetylcarnosine in the treatment of cataracts. Babizhayev MA, Deyev AI, Yermakova VN, Semiletov YA, Davydova NG, Doroshenko VS, Zhukotskii AV, Goldman IM. Drugs R D. 2002;3(2):87-103. PMID: 12001824
- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
- ↑ Stankiewicz et al (1990) "Evaluation of the effectiveness of Quinax in the prevention of the development of senile cataract" PMID=2263035